Business segment information

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Business segment information

11. Business segment information

The Company has two reporting segments: Global Spine and Global Orthopedics. The primary metric used in managing the Company is earnings before interest, tax, depreciation, and amortization (“EBITDA”). Corporate activities are comprised of operating expenses and activities not directly identifiable within the two reporting segments, such as human resources, finance, legal, and information technology functions. The table below presents EBITDA by reporting segment:

	Three Months Ended September 30,						Nine Months Ended September 30,
(U.S. Dollars, in thousands)	2021			2020			2021			2020
Global Spine	$	13,908		$	19,960		$	44,835		$	38,670
Global Orthopedics		(196	)		1,258			(650	)		(3,995	)
Corporate		(8,663	)		(6,196	)		(24,522	)		(16,259	)
Total EBITDA	$	5,049		$	15,022		$	19,663		$	18,416
Depreciation and amortization		(7,151	)		(9,030	)		(22,153	)		(22,299	)
Interest expense, net		(433	)		(731	)		(1,400	)		(2,055	)
Income (loss) before income taxes	$	(2,535	)	$	5,261		$	(3,890	)	$	(5,938	)

Geographical information

The table below presents net sales by geographic destination for each reporting segment and for the consolidated Company:

	Three Months Ended September 30,				Nine Months Ended September 30,
(U.S. Dollars, in thousands)	2021		2020		2021		2020
Global Spine
U.S.	$	79,983	$	83,477	$	246,815	$	215,819
International		6,142		4,339		16,300		12,413
Total Global Spine		86,125		87,816		263,115		228,232
Global Orthopedics
U.S.		6,010		6,356		17,757		16,439
International		20,293		16,813		58,543		44,272
Total Global Orthopedics		26,303		23,169		76,300		60,711
Consolidated
U.S.		85,993		89,833		264,572		232,258
International		26,435		21,152		74,843		56,685
Net sales	$	112,428	$	110,985	$	339,415	$	288,943